Anti-MOG associated disease with intracranial hypertension after COVID-19 vaccination

J Neurol. 2022 Oct;269(10):5647-5650. doi: 10.1007/s00415-022-11130-x. Epub 2022 Apr 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Autoantibodies
  • COVID-19 Vaccines* / adverse effects
  • COVID-19*
  • Humans
  • Intracranial Hypertension* / etiology
  • Myelin-Oligodendrocyte Glycoprotein
  • Vaccination / adverse effects

Substances

  • Autoantibodies
  • COVID-19 Vaccines
  • Myelin-Oligodendrocyte Glycoprotein